In vivo Antifertility and Safety Profiles of Kenyan Moringa oleifera Lam. (Moringaceae) extracts by Kigondu, Elizabeth VM et al.
 Kigondu et al, Afr. J. Pharmacol. Ther. 2016. 5(4): 212-220 
 
A KeSoBAP Publication ©2016. All rights reserved.  ISSN 2303-9841 
212 
 
In vivo Antifertility and Safety Profiles of 
Kenyan Moringa oleifera Lam. (Moringaceae) 
extracts 
Elizabeth V.M. Kigondu a, Moses K. Kamita b, Elizabeth W. Njenga b, James Wanga b, 
Gabriel Amalemba a, and Esther N. Matu a  
a Centre for Traditional Medicine and Drugs Research, Kenya Medical Research Institute 
b Department of Biological Science, University of Eldoret, Kenya 
_____________ 
* Corresponding author: Centre for Traditional Medicine and Drugs Research, Kenya Medical Research Institute, P.O. 
Box 54840-00200, Nairobi, Kenya. Tel: +254-20-2722541; Email: ekigondu@kemri.org         
 
Background: Unsustainable high population growth rate coupled with many women dying of complications of 
unsafe abortion, due to a large number of unwanted pregnancies, has been a challenge in many parts of the world 
especially in developing countries. This indicates that new and alternative contraceptive methods that are safe, cheap 
and convenient are needed. Moringa oleifera Lam (Moringaceae) was selected for this study based on previous 
studies that indicated antifertility effect in rats, of the aqueous extract of the roots and the stem bark. 
Objective: To establish the antifertility properties of M. oleifera. 
Methodology: The aerial parts, seeds, root bark and twigs were extracted using methanol, petroleum ether, 
dichloromethane and ethyl acetate. In vivo antifertility evaluations in Swiss female mice, acute and sub-chronic 
toxicity and phytochemical studies were carried out on M. oleifera extracts.  
Results: The ethyl acetate extract of the seeds of M. oleifera demonstrated reversible antifertility effect at 800mg/kg. 
Physiological tests carried out on mice revealed that the extract arrested the estrus cycle either at the diestrus or the 
proestrus phase by prolonging them. Acute and chronic toxicity evaluation of the extract at 800mg/kg established 
the safety at the tested concentration. Thin layer chromatography (TLC) of the extract revealed the presence of 
terpenoids, steroids and fluorescent compounds, which may be responsible for the antifertility effect that was 
observed.  
Conclusion: The findings validate the ethnomedicinal use of M. oleifera seeds through the establishment of its safety, 
and the antifertility properties that make the extract a potential source of an alternative herbal contraceptive through 
further studies and development.   
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1. Introduction 
Each year, over half a million women die of 
complications of pregnancy, childbearing, and unsafe 
abortion. A vast majority of the deaths occur in 
developing countries (Ziraba et al, 2009; WHO, 2014; 
MoH, 2013). It is estimated that between 10% and 20% 
of these pregnancies are unwanted at the time of 
conception. Thus, up to 100,000 maternal deaths could 
be avoided if women who did not want children used 
effective and acceptable contraceptives (Datey et al, 
1995; WHO, 1997; WHO, 2003; Westhoff et al, 2007; 
WHO, 2012a; 2012b). Lack of use, improper use or 
discontinuation of family planning methods has led to a 
high population growth rate in many countries hence 
causing an imbalance between populations and the 
available resources (Umadevi et al, 2013). In Kenya, 
abandonment of contraceptive use while still in need of 
contraception and contraceptive failure account for 
about 65% of all discontinuations (APHRC, 2001; GoK, 
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1991; WHO, 2012b).  Consequently, Kenya is currently 
grappling with a huge population outburst of about 40 
million people (MSPND, 2010). This situation is in dire 
need of an intervention in order to reduce the number of 
deaths being caused by abortions performed by 
unqualified personnel as well as to reduce the 
population. Traditional birth control method by the use 
of herbal remedies has been in existence for many years 
among various societies (Jain et al, 2004; Kokwaro, 2009; 
Umadevi et al, 2013). Consequently, various studies have 
established different antifertility activities of medicinal 
plants that include anti-implantation, abortification, 
ecobolic, oestrogenic and spermicidal effects (Priya et al, 
2012; Kassem et al, 2005; Tafesse et al, 2005; Ganguly et 
al, 2007; Keshri et al, 2007). This study therefore aimed 
at investigating the antifertility properties of Moringa 
oleifera. Lam (Moringaceae). Studies on M. oleifera 
growing in other parts of the world have shown that 
aqueous extract of the roots and the stem bark, had 
antifertility effect in rats. It exhibited estrogenic, 
antiestrogenic, progestational and antiprogestational 
activities (Shukla et al, 1988; Zade & Dabhadkar, 2015). 
The antifertility effect of Kenyan M. oleifera extracts is 
largely unknown. M. oleifera is a widely distributed plant 
that can survive humid tropics and hot, dry land. In 
Kenya, it is found in Nyanza, Eastern and Coastal regions 
(Beentje et al, 1994). The tree is highly nutritious and has 
been reported to have several ethnomedical uses 
including birth control (Fahey, 2005; Anwar et al, 2007). 
2. Methodology 
2.1 Collection of plant materials 
The plant materials were collected from Kibwezi in 
Makueni County and identified by Mr. Mathias Mbale, a 
plant taxonomist at the East Africa Herbarium-National 
Museums of Kenya, Nairobi, where the voucher 
specimen was deposited (M. oleifera voucher number 
EK710). The plant material [aerial parts (leaves & 
flowers), seeds, root bark and twigs] were separately 
dried under room temperature for 2 weeks then 
pulverized using an electrical mill. The weight of the 
various parts was taken after drying. 
2.2 Extraction 
2.2.1 Organic extraction 
The ground plant material (50-100 g) from each plant 
part were extracted twice with methanol, petroleum 
ether, dichloromethane and ethyl acetate (approx. 200 
ml) by soaking them for 48 h in the respective solvent. 
Samples were then filtered using Whatman® (No.1) 
filter paper. The filtrates were then dried under reduced 
pressure using a rotatory evaporator (Buchi R114) at 
controlled temperature of between 40-60oC and then 
transferred into weighed vials (Mallikharjuna et al, 
2007). The percentage yield was then calculated and 
recorded.  
2.2.2 Aqueous extraction 
Fifty grams of the ground plant material were weighed 
and transferred into a conical flask. The materials were 
then covered with distilled water (100 ml) and placed in 
the water bath at 60oC for 2 h. The samples were then 
filtered and freeze-dried using a freeze drying machine 
(Modulyo EF4). The percentage yield was calculated and 
recorded. 
2.3 In vivo bioassays 
2.3.1 Animal handling 
The research was conducted in accordance with the 
internationally accepted principles for laboratory animal 
use and care as found in the NIH care and use of animals’ 
guidelines. Ethical clearance was sought from KEMRI’s 
Scientific Steering and the Ethical Review Committees. A 
total of 300 (including repeat experiments) healthy 
Swiss mice of both sexes, 8-10 weeks old weighing 18-22 
g, randomly bred at the KEMRI animal house were used 
in the study. The animals were housed spaciously in 
standard polypropylene cages clearly labeled with 
experimental details. The mice were maintained at room 
temperature and 60-70% relative humidity range 
appropriate for their species, with 12 h cycle of day and 
night light conditions. This enabled them to acclimatize 
with minimal stress and physiological alteration. The 
mice were fed on commercial rodent food and water ad 
libitum. A canular was used for oral drug administration. 
The size of the needle that was used to draw blood was 
25 gauges. After the experiment, the mice were 
euthanized. The euthanized mice were then placed in 
biohazard disposable bags for incineration.   
2.3.2 Drug constitution 
On the day of extract administration, each of the organic 
extract was freshly prepared by dissolving in a solution 
consisting of 70% Tween 80, 30% ethanol and diluted 
with double distilled water. The aqueous extracts were 
prepared using distilled water (Houghton & Raman, 
1998). A conventional drug (Femiplan®, levonogestrel: 
0.15 mg & ethinylestradiol: 0.03 mg) was used as the 
positive control. The effective concentration of the 
femiplan was determined by administering three doses 
of 180, 90 and 45 mg/kg to determine the lowest 
effective dose of the drug in mice. Both 180 and 90 mg/kg 
were effective in controlling the fertility of the mice. 
However, 45 mg/kg concentration was not effective in 
controlling the fertility of the mice. In the subsequent 
experiments, 90 mg/kg was taken to be the lowest 
effective dose and was used as the positive control. 
2.3.3 Fertility test 
Fifty female mice were divided into 5 mice per cage. In 
each cage a male was introduced to the female mice and 
were allowed to mate. After two weeks, the male mice 
were withdrawn after pregnancy sign (bulging stomach) 
was noted in some of the female mice. The expectant 
females delivered and the number of pups noted. Those 
that did not conceive were separated from the pregnant 
mice and were considered infertile at the time and were 
not used in the subsequent experiments (Mali et al, 
2002). 
Screening for the anti-fertility effect in mice 
This study was carried out according to the method 
described by Ganguly et al (2007). Eleven groups (each 
group containing 3 fertile female mice) were selected for 
the study. Eight groups received different extracts while 
3 groups received distilled water, Tween 80 and 
 Kigondu et al, Afr. J. Pharmacol. Ther. 2016. 5(4): 212-220 
 
 
A KeSoBAP Publication ©2016. All rights reserved.  ISSN 2303-9841 
214 
femiplan as controls. The drug administration was first 
carried out for 8 days before the introduction of males. 
All the experimental mice were then allowed to mate 
with the identified fertile male mice, and the drug 
administration continued for 21 days. The number of 
litters was determined after the completion of one 
gestation period of 21 days in all experimental groups. 
The study was independently repeated and the average 
of the two studies determined.  
Reversibility test 
The reversibility of the anti-fertility effect of the extracts 
was also studied in the treated groups according to the 
method described by Salhab et al (1997). Briefly, the 
active extract was administered at 800 mg/kg 
continuously to a group of 3 mice for 21 days, and then 
withdrawn. After 21 days of extract withdrawal, animals 
were allowed to mate with male mice. The number of 
litters was determined after the completion of one 
gestation period. The study was independently repeated 
and the average of the two studies determined. 
Effect of the ethyl acetate extract of the seeds of M. 
oleifera on the estrus cycle  
Five fertile female mice were employed for the study. 
Vaginal smears from each animal were examined under 
a microscope once per day every morning between 9.00 
and 10.00 am for 21 days. This accounted for about 4 - 5 
cycles. Each mouse was held in a supine position and the 
vaginal secretion was collected after cleansing with 0.2 
ml of normal saline (NaCl 0.9%) contained in a smooth 
plastic pipette and placed in a tube (Marcondes et al, 
2002). A small drop of the cell suspension was then 
placed on a glass slide and examined under a light 
microscope at x10 and x40 magnification. The cell 
suspension was evaluated to determine the phases of 
estrus cycle using the proportion of characteristic cell 
types such as the leucocytes, cornified and epithelial cells 
(Abu & Uchendu, 2011; Malaivijitnond et al, 2006). The 
duration of the estrus cycle together with that of the 
various phases was determined as described by 
Makonnen et al (1997) for 21 days. Administration of the 
test drug (ethyl acetate extracts of the seeds at 800 
mg/kg) followed and the same parameters were 
determined. 
Effect of the ethyl acetate extract of the seeds of M. 
oleifera on the weight of genital organ and body 
weight  
The experiment was done according to Makonnen et al 
(1997) with some few modifications. Five groups of 5 
female mice in each group were employed. The 
experimental mice received the test extract at 800 mg/kg 
and the control groups received distilled water and 10% 
Tween 80, for 10 days through the oral route. On the 11th 
day, all the animals in all the groups were weighed and 
sacrificed. The ovaries and uteri were resected, 
separated from the surrounding tissues, and then blotted 
on aluminum foils (Gebrie et al, 2005). The organs were 
weighted and a ratio calculated by dividing the weight of 
the ovary, as well as, that of the uterine in milligrams by 
body weight in grams. The rise in the uterine ratio was 
an indication of the estrogenic effect of the extract as 
described by Vogel (1997).  
2.3.4 Acute toxicity assay 
The acute toxicity effect of the bioactive extracts was 
carried out according to the method described by 
Mukinda and Syce (2007). Briefly, 8 groups consisting of 
5 female mice per group were used in this experiment. 
The doses of the bioactive extracts administered in single 
doses orally were 0, 1000, 2000, 3000, 4000 and 5000 
mg/kg. The general behavior of the mice was 
continuously monitored for 1 h after dosing, periodically 
during the ﬁrst 24 h especially the ﬁrst 4 h (Hilaly et al, 
2004), and then daily thereafter, for a total of 14 days. 
Changes in the normal activity of mice and their weights 
were monitored and the time at which signs of toxicity or 
death appeared recorded. 
2.3.5 Sub-chronic toxicity study in mice 
The study was carried out according to Mukinda and 
Syce (2007) with some few modifications. Female mice 
were housed in 5 (I-V) groups of 5 animals. The mice 
were first left for 7 days to acclimatize to laboratory 
conditions. The extracts were administered orally, daily 
for 3 months, to the groups I to VI at treatment doses of 
0, 100, 1000 and 2000 mg/kg respectively. In the treated 
animals, differences in their normal behaviour, fur 
condition, discharge, movements and mortality of the 
mice were monitored daily. Changes in body weight and 
food intake were recorded weekly. At the end of the 3 
month-experiment, all the animals were euthanized and 
blood samples collected through cardiac puncture into 
EDTA containing tubes and in plain tubes for 
haematological and biochemical analyses respectively. 
The collected blood samples were analyzed using a 
hemoanalyzer machine (URIT-3300).   
2.4 Phytochemical screening of the bioactive 
extract 
Phytochemical screening of the extracts of the seeds of 
M. oleifera was carried out using thin layer 
chromatography (TLC) to determine the presence of 
secondary metabolites such as steroids, terpenoids, 
tannins, flavonoids, alkaloids, saponins, glycosides and 
reducing sugars (Harborne, 1998; Mallikharjuna et al, 
2007).  
2.5 Statistical analysis 
The litter number and weight of the uterus and body 
weight ratio were expressed as mean ± standard 
deviation (S.D). For the hematological and biochemical 
parameters, a significant difference between control and 
experimental groups was assessed by the use of 
Student’s t-test while the analysis of variance (ANOVA) 
was used to assess any significant difference among the 
groups. The level of significance was set at ρ values less 
than 0.05. 
3.  Results and Discussion 
Collection and extraction 
The weights of the various plant parts of M. oleifera 
(voucher number EK710) were: aerial parts (leaves & 
flowers) - 1.45 Kg, seeds – 1 Kg, root bark – 0.62 Kg and 
twigs – 0.31 Kg. Extraction was carried out using 
dichloromethane, methanol, ethyl acetate and water. The 
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percentage yields of the extracts are summarized in 
Table 1. Extraction of the root bark and seeds using 
dichloromethane resulted in the highest yields of 
extracts (Table 1). 
Table 1: Percentage yields (%) of the M. oleifera extracts 
Part PE CH2Cl2 AcOEt MeOH H2O 
Aerial parts 1.4 nd 1.04 3.32 nd 
Root bark 0.73 1.08 0.36 3.43 13.36 
Seeds 13.68 19.87 15.01 1.56 11.08 
Twigs 0.4 1.78 1.06 4.80  
PE - petroleum ether; CH2Cl2 – dichloromethane; MeOH – 
methanol; H2O – water; nd – not done 
Fertility Test 
Determination of the fertility in the female mice gave a 
rate of 60%. The results of fertility test suggested that 
some of the mice were not receptive for the 21 days that 
the male mice were in the cage, and thus did not give 
birth during the first gestation period. The litter size per 
mouse recorded an average of 6. The mice that gave birth 
were considered as fertile and were used in the 
screening for the antifertility activity of the candidate 
plants. 
Antifertility and reversibility effect 
Ethyl acetate extract of the seeds of M. oleifera 
demonstrated the highest antifertility effect (Table 2) 
since the female mice did not bear offspring after 
exposure to the male. 
On withdrawal of the extract, the female mice on 
exposure to the male, conceived and bore an average of 
6 pups, a value comparable to the positive control (mice 
administered with femiplan) and the negative control 
(fertile mice not treated, Table 3), indicating that the 
antifertility effect of the extract is reversible. In previous 
studies antifertility effect was reported in the aqueous 
and alcohol extracts of the roots and the stem bark of M. 
oleifera respectively (Shukla et al, 1988; Prakash et al, 
1987; Zade & Dabhadkar, 2015). However, no reports 
have indicated that the seeds have an antifertility effect. 
Ethanol and aqueous extracts of the seeds have been 
found to have other biological activities such as 
antimicrobial, antitumor, antioxidant activities amongst 
others (Guevara et al, 1999; Fahey, 2005; Anwar et al, 
2007). 
Table 2: Fertility of female mice after 21 days of treatment with 800mg/kg of test extracts (Male: Female ratio, 1:3) 
Extract Solvent Extract dose mg/kg No. of fertile/treated mice Litter size ±S.D 
M. oleifera (seed) Pet ether 800 2/3 8.00±1.0 
Ethyl acetate 800 0/3 0 
DCM 800 3/3 9.00±0.58 
Water  800 3/3 6.67±0.33 
M. oleifera (Twigs) Methanol 800 3/3 7.33±0.33 
M. oleifera (Root bark) Methanol 800 3/3 6.00±0.58 
Water  800 2/3 6.00±0.50 
M. oleifera (aerial) Methanol 800 3/3 6.00±0.58 
Negative control  Water N/A 3/3 8.00±0.58 
Tween 80 10% 2/3 6.00±1.00 
Positive control 
(FemiplanTM) 
 90 0/3 0 
The data is an average of two independent experiments. 
 
Table 3. Fertility of female mice after 21 days of treatment after withdrawal of the treatment during a repeat of the 
experiment 





No. of fertile/ 
treated mice 
Total no. of pups 
per group 






800 3/3 16 5.3±1.41 
Femiplan Water  180 3/3 20 6.7±0.58 
Femiplan Water  90 3/3 22 7.3±0.58 
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Effect of the ethyl acetate extract of the seeds of M. 
oleifera on the estrus cycle  
The estrus cycle in mice occurs over 4 - 5 days in 4 stages: 
the proestrus stage (pre-ovulatory day) and the 
ovulatory stages, which include estrus, metestrus and 
diestrus stages defined by different forms of epithelial, 
cornified and leukocyte cells (Caligioni, 2009). 
Observation of the vaginal smears using microscopy 
provides information on the stage and the length of the 
cycle of a mouse (Makonnen et al, 1997). During 
treatment of the female mice with the ethyl acetate 
extract of the seeds, the length of the estrus cycle in all 
the treatment groups was significantly changed as 
compared with the control group that received distilled 
water. Mice in the control group exhibited a regular 
estrus cycle of 4 to 5 days. The extract arrested the 
normal estrus cycle at either the diestrus or the 
proestrus phase. The diestrus and proestrus phases of 
the cycle of the treated mice were prolonged in the 
treated groups. However, the estrus and metestrus 
phases of the treated mice were highly reduced in the 
treatment group. Similar observations of prolonged 
estrus and diestrus phases (by 48 h) were observed 
when albino rats were administered with the alcohol 
extract of the stembark of M. oleifera in a study carried 
out by Zade & Dabhadkar, 2015. During the 
administration of ethyl acetate extract of M. oleifera 
seeds, the mice exhibited diestrus phase for most of the 
days, followed by proestrus phase and only one day for 
some of the mice exhibited the estrus and metestrus 
phases. The disruption of the estrus cycle is a likely 
mechanism of action of the M. oleifera seed extract in 
mice and should further be investigated. 
Effect of the extract on the weight of genital organ 
and body weight 
Generally, the ethyl acetate extract of the seeds of M. 
oleifera did not have a suppressive effect on the ovary as 
well as the uterus (Figure 1). At a concentration of 
800mg/kg the extract administered for 10 days did not 
affect the uterine fresh weight significantly (ρ = 0.077), 
as well as, the fresh weight of the ovaries (ρ = 0.145). This 
indicates that even though the seed extract inhibits 
conception in mice, the mechanism of action of the 
extract does not involve altering of the physiology of the 
ovaries or the uterus. 
Acute toxicity assay 
Interestingly, administration of the ethyl acetate extracts 
of M. oleifera seed showed no death or signs of toxicity 
up to 4000mg/kg. However, at the highest tested dose 
(5000mg/kg) there were mild signs of toxicity that 
included hypo-activity, low appetite, and piloerection. 
This observation was comparable to the negative 
control. It is worth noting that at 5000mg/kg the toxicity 
was noted for 1 h however, after the 2nd h after extract 
administration, most of the mice had regained their 
normal activity, as well as appetite. Keeping in mind that 
the antifertility active concentration of the extract is 
800mg/kg, it can be deduced that the plant extract is safe 
at the active concentration. Previous reports indicated 
that the alcoholic extract of the stem bark of M. oleifera 
did not exhibit acute toxicity in rats (Zade & Dabhadkar, 
2015). 
Figure 1: The effect of the ethyl acetate extract of the M. oleifera, (seed) in comparison with the control on wet weight 
of mice uterus and the ovaries 
Sub-chronic toxicity study in mice: Effect of oral 
Moringa oleifera ethyl acetate extract of the seeds, on 
the general behavior of mice 
Oral administration of the ethyl acetate extract of the 
seeds of M. oleifera caused no noticeable change in the 
general behavior of the mice for the first two months of 
extract administration. However, the fur, movement and 
the general activity of the mice differed from the control 
group. Interestingly, the weight of the mice that received 
the extract at 100mg/kg, was higher than that of the 
control group (Figure 2). This may have been observed 
due to the nutritional benefits associated with the M. 
oleifera seeds at the given concentration (Fahey, 2005; 
Anwar et al, 2007). The amount of food intake between 
the two groups (control and those administered with 
100mg/kg of extract) was comparable. On the other 
hand, the mean weight of the mice that received 
1000mg/kg and 2000mg/kg extract dropped, compared 
to the control group, an indication that administration of 
a high dose of the extract may have affected the appetite 
of the mice, hence causing a reduction in food-intake. 
Similar observations were made in a study by Adedapo 
et al 2009, where a drop in the weight of rats was 
reported after administering an aqueous extract of M. 
oleifera leaves; the weight reduction increased with an 
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increase of the dose administered (400 - 1600mg/kg).  In 
addition to a weight reduction in this study, the mice 
manifested minor symptoms of toxicity comprising 
rough fur and partial hypo-activity. However, no deaths 
occurred at any of the doses (up to 2000mg/kg) 
administered indicating that the LD50 for chronic oral 
dosing with M. oleifera extract was much higher than 
2000mg/kg. This further confirms that the plant extract 
is safe at the active concentration (800mg/kg), however, 
further histopathological investigations need to be 
carried out to conclusively confirm that the extract is safe 
in mice at the given concentration. 
Sub-chronic toxicity study in mice: Effect of oral 
Moringa oleifera ethyl acetate extract on the 
hematological and biochemical parameters of mice 
The parameters analyzed included white blood cells 
(WBC), red blood cells (RBC), hemoglobin, hematocrit 
and platelet levels.  All the parameters for the treated 
mice and the negative control were comparable. For 
instance, the WBC levels in groups that received 
100mg/kg, 1000mg/kg and 2000mg/kg were 7.280 x 
109, 6.920 x 109 and 7.600 x 109/L respectively (Table 
4). In the control group, the level of the WBC was 7.980 x 
109/L. At ρ<0.05, significant difference in each group was 
checked versus the controls. There were no parameters 
in any test group that showed significant difference 
against the control hence the ethyl acetate extracts of M. 
oleifera seed can be said to be safe at 800mg/kg.   
The hematological parameters, such as hematocrit, 
hemoglobin concentration, platelets, red and white 
blood cells in the treated mice did not differ significantly 
from those of the control group (Table 4). This is in 
agreement with published hematological parameters 
that were determined for adult Balb/c mice, but with a 
few differences in the levels of WBC and platelets that 
may have occurred due to the genetic differences in the 
two species of mice (Nemzek et al, 2001). Hematological 
parameters are some of the targets for toxic compounds 
and may thus act as indicators of toxicity (Diallo et al, 
2010). Thus the extract did not have effects on the 
circulating cells neither did it affect their production. 
A significant difference of treatment-related changes 
was not observed in the levels of plasma analytes as 
compared to the control group (Table 4). However, a 
significant reduction in the levels of alanine 
transaminase (p = 0.0018 & 0.00055 at 100 & 
2000mg/kg respectively), aspartate aminotransferase (p 
= 0.000016 at 2000 mg/kg) and total cholesterol (p = 
0.0204 & 0.00095 at 1000 & 2000 mg/kg respectively) 
was noted. Elevated alanine transaminase and aspartate 
aminotransferase are biomarkers that predict toxicity 
and damage in the liver (Campion et al, 2013) however, 
lower values have not been reported to be a cause of liver 
toxicity but may serve as an independent predictive 
marker for increased long term mortality (Ramaty et al, 
2014). The reduction of cholesterol at higher extract 
concentrations may have resulted from the changes in 
normal behavior in mice characterized by low appetite 
and hypo-activity rather than liver toxicity. It may also 
have been due to antiatherogenic effects resulting from 
metabolic effects that enhance glucose uptake as 
reported in other studies in which hypoglycemia effect of 
methanol and aqueous extracts of the leaves of M. 
oleifera was observed (Abd et al, 2014; Olayaki et al, 
2015). It is worth noting that no significant difference 
was observed in creatinine level, which is an indicator of 
the kidney function (Campion et al, 2013). Based on the 
results presented here, it can be concluded that the ethyl 
acetate seed extract is safe at the effective dose. 
Phytochemical screening 
Thin layer chromatography (TLC) of extracts of the seeds 
of M. oleifera revealed the presence of various 
compounds or secondary metabolites. The test indicated 
the presence of terpenoids, alkaloids, phenols, glycosides 
and steroids in the various seed extracts. The ethyl 
acetate seed extract mainly consisted of terpenoids, 
steroids and fluorescent compounds. Compounds that 
have previously been isolated from the seeds of M. 
oleifera include: O-ethyl-4-(α-L-rhamnosyloxy)benzyl 
carbamate, 4(α-L-rhamnosyloxy)-benzyl isothiocyanate, 
niazimicin, 3-O-(6’-O-oleoyl-β-D-glucopyranosyl)-β-
sitosterol, β-sitosterol-3-O-β-D-glucopyranoside, 
niazirin, β-sitosterol and glycerol-1-(9-octadecanoate), 
most of which are associated with various bioactivities 
(Faizi et al, 1998; Guevara et al, 1999; Anwar et al, 2007; 
Galuppo et al, 2013; Hussain et al, 2014). Hence the 
compounds already identified in the seeds of M. oleifera 
and others that may be present but unknown, can be 
further investigated for antifertility effect. 
Figure 2: Changes in the body weight of mice after chronic oral treatment with an ethyl acetate extract of M. oleifera 
seed 
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Table 4: The effect of M. oleifera extract on the whole blood count and biochemical blood parameters of mice after 3 
months daily oral dosing  
Parameters 
Dose of ethyl acetate extracts 
0mg/kg 100mg/kg 1000mg/kg 2000mg/kg 
White Blood Cells x 109/L 7.980±1.5803 7.280±0.7889 6.920±0.8737 7.600±0.4593 
RBC x 1012/L 8.9040±0.35004 9.0680±0.10131 8.7340±0.05464 8.7820±0.20984 
Hemoglobin (g/dL) 14.700±0.4615 14.840±0.2694 14.360±0.1939 13.880±0.2596 
Hematocrit (%) 46.660±2.1653 51.140±0.7194 49.120±0.7559 50.380±2.0781 
Platelet x 109/L 443.20±55.356 430.00±31.420 467.00±9.721 493.40±44.002 
Alanine transaminase IU/L 56±0.84 51±0.71* 57±0.71 49±0.95* 
Aspartate aminotransferase IU/L 180±2.12 180±1.52 187±2.05 154±1.89* 
Creatinine μmol/L 104±2.59 113±3.38 107±2.92 107±3.31 
Total Cholesterol mmol/L 7.8±0.31 7.5±0.18 6.7±0.18* 5.5±0.13* 
The data are expressed as mean ± S.E.M; AST activity levels increased with age (time); *values with p < 0.05 
4. Conclusion 
This study has established that the seeds of M. oleifera 
Lam. have antifertility properties and most importantly 
they are safe at the active concentration. The findings 
indicate that with further investigations the seeds have 
the potential to be developed as an affordable herbal 
contraceptive. It further validates the ethnomedical use 
of the plant amongst various indigenous communities. 
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